The stock value of Regulus Therapeutics Inc. (NASDAQ: RGLS) has increased significantly, rising by 116.67% to $2.99 per share during the current trading session. This
On January 20, Regulus Therapeutics Inc. (RGLS) announced the successful completion of the pre-IND meeting for RGLS8429 with the FDA. Consequently, the stock advanced further
On December 8, American stock exchanges closed at historic highs. The S&P 500 Index climbed 0.28% to 3702 points, the Dow Jones added 0.35%, the
This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.